Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GM-CSF Priming with Chemotherapy in Multiple Myeloma
NCT00003490Phase 2Completed
- Sponsor
- Cleveland Clinic
- Start
- Oct 1998
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of sargramostim in multiple myeloma (MM), sponsored by Cleveland Clinic. Started Oct 1998; status: completed.
02
Drugs
sargramostim
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00003490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003490.